GLP-1 Receptor Agonist Market Size and Trends Forecast: 2026 - 2033 GLP-1 receptor agonist market is estimated to be valued at USD 31.71 Bn in 2026 and is expected to reach USD 72.33 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2026 to 2033
They contain high levels of a man-made version of B12 called cyanocobalamin
But a huge number of meat eaters are also deficient and likely dont know it B12 is absorbed through the stomach, and our ability to assimilate it through the stomach wall decreases with age, as well as due to any stomach issues like IBS, Crohns, and Celiac Disease, and medications that impact the stomach like metformin, antacids, PPIs, and ibuprofen
GLP-1 Use Reaches a New High New evidence suggests GLP-1 usage continues to expand quickly
(1998) "Ipamorelin, the first selective growth hormone secretagogue." Published in European Journal of Endocrinology
Could GLP-1s become part of addiction treatment in the future